Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/30411328/ below:

The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening

Affiliations

• ¹ Department of Mammography, Falun Central Hospital, Falun, Sweden.
• ² Department of Radiology, University of Turku, Turku, Finland.
• ³ Graduate Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan.
• ⁴ School of Oral Hygiene, Collage of Oral Medicine, Taipei Medical University, Taipei, Taiwan.
• ⁵ Department of Nutrition and Health Sciences, Kainan University, Taoyuan, Taiwan.
• ⁶ Department of Health Care Management, Chang Gung University, Taoyuan, Taiwan.
• ⁷ Department of Radiation Sciences, Umeå University, Umea, Sweden.
• ⁸ Department of Biostatistics, Taipei City Hospital, Taipei, Taiwan.
• ⁹ Center for Population Health Research, University of South Australia, Adelaide, Australia.
• ¹⁰ Cancer Control Department, and Center for Quality Cancer Screening and Research, American Cancer Society, Atlanta, Georgia.
• ¹¹ Center for Cancer Prevention, Queen Mary University of London, London, United Kingdom.

• PMID: 30411328
• PMCID: PMC6588008
• DOI: 10.1002/cncr.31840

Item in Clipboard

László Tabár et al. Cancer. 2019.

• ¹ Department of Mammography, Falun Central Hospital, Falun, Sweden.
• ² Department of Radiology, University of Turku, Turku, Finland.
• ³ Graduate Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan.
• ⁴ School of Oral Hygiene, Collage of Oral Medicine, Taipei Medical University, Taipei, Taiwan.
• ⁵ Department of Nutrition and Health Sciences, Kainan University, Taoyuan, Taiwan.
• ⁶ Department of Health Care Management, Chang Gung University, Taoyuan, Taiwan.
• ⁷ Department of Radiation Sciences, Umeå University, Umea, Sweden.
• ⁸ Department of Biostatistics, Taipei City Hospital, Taipei, Taiwan.
• ⁹ Center for Population Health Research, University of South Australia, Adelaide, Australia.
• ¹⁰ Cancer Control Department, and Center for Quality Cancer Screening and Research, American Cancer Society, Atlanta, Georgia.
• ¹¹ Center for Cancer Prevention, Queen Mary University of London, London, United Kingdom.

• PMID: 30411328
• PMCID: PMC6588008
• DOI: 10.1002/cncr.31840

Item in Clipboard

Background: Women and their health care providers need a reliable answer to this important question: If a woman chooses to participate in regular mammography screening, then how much will this choice improve her chances of avoiding a death from breast cancer compared with women who choose not to participate?

Methods: To answer this question, we used comprehensive registries for population, screening history, breast cancer incidence, and disease-specific death data in a defined population in Dalarna County, Sweden. The annual incidence of breast cancer was calculated along with the annual incidence of breast cancers that were fatal within 10 and within 11 to 20 years of diagnosis among women aged 40 to 69 years who either did or did not participate in mammography screening during a 39-year period (1977-2015). For an additional comparison, corresponding data are presented from 19 years of the prescreening period (1958-1976). All patients received stage-specific therapy according to the latest national guidelines, irrespective of the mode of detection.

Results: The benefit for women who chose to participate in an organized breast cancer screening program was a 60% lower risk of dying from breast cancer within 10 years after diagnosis (relative risk, 0.40; 95% confidence interval, 0.34-0.48) and a 47% lower risk of dying from breast cancer within 20 years after diagnosis (relative risk, 0.53; 95% confidence interval, 0.44-0.63) compared with the corresponding risks for nonparticipants.

Conclusions: Although all patients with breast cancer stand to benefit from advances in breast cancer therapy, the current results demonstrate that women who have participated in mammography screening obtain a significantly greater benefit from the therapy available at the time of diagnosis than do those who have not participated.

Keywords: breast cancer; fatality; mammography; mortality; screening.

© 2018 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society.

PubMed Disclaimer

Dr. Tabár reports personal fees from General Electric Healthcare for preparing automated breast ultrasound teaching cases, and honoraria and travel costs to General Electric Healthcare speaking engagements; personal fees from Mammography Education, Inc. in his capacity as president of the company, which organizes CME courses on breast imaging; and personal fees from Three Palm Software for consultation related to breast imaging interpretation, all outside the submitted work. The other authors made no disclosures.

Annual population of women ages…

Annual population of women ages 40 to 69 years who did and did…

Annual population of women ages 40 to 69 years who did and did not participate in mammography screening (data from statistics of Dalarna County, Sweden, from 1958 to 2015).

The incidence of (A) breast…

The incidence of (A) breast cancer and of (B) breast cancer fatal within…

The incidence of (A) breast cancer and of (B) breast cancer fatal within 10 years and (C) breast cancer fatal within 11‐20 years among women who did and did not participate in mammography screening is illustrated. All values indicate 5‐year moving averages for women ages 40 to 69 years (data from statistics of Dalarna County, Sweden, from 1958 to 2015)

• Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women.

  Duffy SW, Tabár L, Yen AM, Dean PB, Smith RA, Jonsson H, Törnberg S, Chen SL, Chiu SY, Fann JC, Ku MM, Wu WY, Hsu CY, Chen YC, Svane G, Azavedo E, Grundström H, Sundén P, Leifland K, Frodis E, Ramos J, Epstein B, Åkerlund A, Sundbom A, Bordás P, Wallin H, Starck L, Björkgren A, Carlson S, Fredriksson I, Ahlgren J, Öhman D, Holmberg L, Chen TH. Duffy SW, et al. Cancer. 2020 Jul 1;126(13):2971-2979. doi: 10.1002/cncr.32859. Epub 2020 May 11. Cancer. 2020. PMID: 32390151 Free PMC article.

• Mammography screening: A major issue in medicine.

  Autier P, Boniol M. Autier P, et al. Eur J Cancer. 2018 Feb;90:34-62. doi: 10.1016/j.ejca.2017.11.002. Epub 2017 Dec 20. Eur J Cancer. 2018. PMID: 29272783

• Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.

  Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Miller AB, et al. BMJ. 2014 Feb 11;348:g366. doi: 10.1136/bmj.g366. BMJ. 2014. PMID: 24519768 Free PMC article. Clinical Trial.

• [Screening for breast cancer: worries about its effectiveness].

  Autier P. Autier P. Rev Prat. 2013 Dec;63(10):1369-77. Rev Prat. 2013. PMID: 24579331 Review. French.

• Long-term effects of mammography screening: updated overview of the Swedish randomised trials.

  Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Nyström L, et al. Lancet. 2002 Mar 16;359(9310):909-19. doi: 10.1016/S0140-6736(02)08020-0. Lancet. 2002. PMID: 11918907 Review.

• Changes in Disparities in Stage of Breast Cancer Diagnosis in Pennsylvania After the Affordable Care Act.

  Spada NG, Geramita EM, Zamanian M, van Londen GJ, Sun Z, Sabik LM. Spada NG, et al. J Womens Health (Larchmt). 2021 Mar;30(3):324-331. doi: 10.1089/jwh.2020.8478. Epub 2020 Sep 28. J Womens Health (Larchmt). 2021. PMID: 32986501 Free PMC article.

• Deep Learning Models for Automated Assessment of Breast Density Using Multiple Mammographic Image Types.

  Rigaud B, Weaver OO, Dennison JB, Awais M, Anderson BM, Chiang TD, Yang WT, Leung JWT, Hanash SM, Brock KK. Rigaud B, et al. Cancers (Basel). 2022 Oct 13;14(20):5003. doi: 10.3390/cancers14205003. Cancers (Basel). 2022. PMID: 36291787 Free PMC article.

• Does Diffusely Infiltrating Lobular Carcinoma of the Breast Arise from Epithelial-Mesenchymal Hybrid Cells?

  Tabár L, Bozó R, Dean PB, Ormándi K, Puchkova O, Oláh-Németh O, Németh IB, Veréb Z, Yen MF, Chen LS, Chen HH, Vörös A. Tabár L, et al. Int J Mol Sci. 2023 Jun 28;24(13):10752. doi: 10.3390/ijms241310752. Int J Mol Sci. 2023. PMID: 37445938 Free PMC article.

• Worldwide Review and Meta-Analysis of Cohort Studies Measuring the Effect of Mammography Screening Programmes on Incidence-Based Breast Cancer Mortality.

  Dibden A, Offman J, Duffy SW, Gabe R. Dibden A, et al. Cancers (Basel). 2020 Apr 15;12(4):976. doi: 10.3390/cancers12040976. Cancers (Basel). 2020. PMID: 32326646 Free PMC article. Review.

• A Breast Cancer Polygenic Risk Score Is Feasible for Risk Stratification in the Norwegian Population.

  Akdeniz BC, Mattingsdal M, Dominguez-Valentin M, Frei O, Shadrin A, Puustusmaa M, Saar R, Sõber S, Møller P, Andreassen OA, Padrik P, Hovig E. Akdeniz BC, et al. Cancers (Basel). 2023 Aug 16;15(16):4124. doi: 10.3390/cancers15164124. Cancers (Basel). 2023. PMID: 37627152 Free PMC article.

1. 1. Jonsson H, Nystrom L, Tornberg S, Lenner P. Service screening with mammography of women aged 50–69 years in Sweden: effects on mortality from breast cancer. J Med Screen. 2001;8:152‐160. - PubMed
2. 1. Jonsson H, Bordas P, Wallin H, Nystrom L, Lenner P. Service screening with mammography in northern Sweden: effects on breast cancer mortality—an update. J Med Screen. 2007;14:87‐93. - PubMed
3. 1. Tabar L, Vitak B, Chen TH, et al. Swedish 2‐County Trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011;260:658‐663. - PubMed
4. 1. Toikkanen SP, Kujari HP, Joensuu H. Factors predicting late mortality from breast cancer. Eur J Cancer. 1991;27:586‐591. - PubMed
5. 1. Joensuu H, Pylkkanen L, Toikkanen S. Late mortality from pT1N0M0 breast carcinoma. Cancer. 1999;85:2183‐2189. - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3